← Eichor
Condition: Placebo Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Placebo

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Phase 3 Study of Sunvozertinib Versus Placebo as Adjuvant Therapy in Patients With Early-Stage Non-Small Cell Lung Can
Phase 3 · 49 location(s) · Dizal (Jiangsu) Pharmaceutical Co., Ltd. · NCT07182682A Study of IPN10200 for the Treatment of Cervical Dystonia in Adults
Phase 2 · 44 location(s) · Ipsen · NCT06937931A Study of CS0159 in Patients With PBC With Inadequate Response or Intolerance to UDCA
Phase 3 · 42 location(s) · Cascade Pharmaceuticals, Inc · NCT07282353Vasopressin and Pain Perception in the Brain
Phase 1/Phase 2 · 1 location(s) · University of Maryland, Baltimore · NCT03446456A Mechanistic Study on the Effect of HTD1801 Versus Placebo on Kidney Function in Patients With Type 2 Diabetes and Chro
Phase 2 · 1 location(s) · Institute of Medicinal Biotechnology, Chinese Academy of Med · NCT07496177A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older
Phase 3 · 174 location(s) · Pfizer · NCT07282665Proof of Concept Study on BP1.4979 Effect on Essential Tremor
Phase 2 · 14 location(s) · Bioprojet · NCT07074002Cranberry Polyphenols and Stress Resilience During Multitasking in Healthy Adults
NA · 1 location(s) · University of Florida · NCT07453537Efficacy and Safety of Human Urinary Kallidinogenase Combined With Endovascular Therapy in Acute Ischemic Stroke With La
NA · 1 location(s) · Huashan Hospital · NCT06211712Effects of Single Sodium Bicarbonate Supplementation on National-Level Finswimming Performance
NA · 1 location(s) · Palacky University · NCT07135934Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Alzheimer's Disease Dementia
Phase 2/Phase 3 · 49 location(s) · Exciva GmbH · NCT07284472A Study to Evaluate Features of KN069 in Participants With Obesity or Overweight
Phase 1 · 1 location(s) · Suzhou Alphamab Co., Ltd. · NCT06547775A Phase 2 Trial of Dotinurad in Xanthine Oxidase Inhibitor (XOI) Intolerant/Uricase Failure Gout Participants
Phase 2 · 17 location(s) · Crystalys Therapeutics · NCT07535034Study Evaluating the Safety, Efficacy and Pharmacokinetics of SYH9089 Injection in Patients Undergoing Abdominal Surgery
Phase 1 · 1 location(s) · CSPC Ouyi Pharmaceutical Co., Ltd. · NCT07519109Early Antiplatelet Administration After Intravenous Thrombolysis for Acute Ischemic Stroke (TREND-IVT)
Phase 3 · 71 location(s) · Capital Medical University · NCT06548971A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's Dementia
Phase 2 · 70 location(s) · Intra-Cellular Therapies, Inc. · NCT06651567To Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of GB18 Injection in Health
Phase 1 · 1 location(s) · Shenzhen Kexing Pharmaceutical Co., Ltd. · NCT07237464Suvorexant as an Adjunct to Buprenorphine in Persons Who Use Fentanyl
Phase 2 · 1 location(s) · Johns Hopkins University · NCT05145764A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-A1 in Healthy Young Adults
Phase 1 · 1 location(s) · Vaxcyte, Inc. · NCT07616934Perineural vs Intravenous Dexamethasone as an Adjuvant to Brachial Plexus Block in Pediatric Hand Surgery
NA · 1 location(s) · Poznan University of Medical Sciences · NCT07474909PF614 Analgesic Activity in Acute Postoperative Pain (PF614-301)
Phase 3 · 3 location(s) · Ensysce Biosciences · NCT06602271A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressi
Phase 3 · 60 location(s) · Neurocrine Biosciences · NCT07196501This Randomized Trial Aims to Investigate the Efficacy of Balanced Nutritional Tablets-Comprehensive Multivitamin and Mi
Phase 4 · 1 location(s) · General Committee of Teaching Hospitals and Institutes, Egyp · NCT06981936Efficacy and Safety of BRIMOCHOL PF and CARBACHOL PF in Chinese Presbyopia Patients
Phase 2 · 1 location(s) · Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. · NCT06948357Phase 2b Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food Allergy
Phase 2 · 37 location(s) · RAPT Therapeutics, Inc. · NCT07220811Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
Phase 3 · 68 location(s) · Intra-Cellular Therapies, Inc. · NCT06372964A Multicentre, Randomised, Double-blind, Placebo-parallel Controlled Phase Ⅲ Clinical Trial Evaluating the Efficacy and
Phase 3 · 9 location(s) · Biocells (Beijing) Biotech Co.,Ltd · NCT07520565Intravenous Ketamine for Treatment-Resistant Depression
Phase 2 · 1 location(s) · Mayo Clinic · NCT06668571A Study Evaluating the Safety and Immunogenicity of MVA Strain Monkeypox Attenuated Live Vaccine
Phase 1 · 1 location(s) · Shanghai Institute Of Biological Products · NCT06771479A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Phase 3 · 173 location(s) · Eli Lilly and Company · NCT07392190
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.